Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

Expression of microRNAs in the Urine of Patients With Bladder Cancer

(2012) Gang Wang et al.   Clinical Genitourinary Cancer

Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma

(2012) Imke Sanders et al.   INTERNATIONAL JOURNAL OF UROLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

(2011) Jason C. Gonzales et al.   Clinical Genitourinary Cancer

MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma

(2011) Yukako Imanaka et al.   JOURNAL OF HUMAN GENETICS

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

(2011) Xiao-Guang Liu et al.   MEDICAL ONCOLOGY

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

(2011) Hanyin Cheng et al.   PLoS One

MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing

(2011) Yonghua Han et al.   PLoS One

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

(2011) Lena M. Wulfken et al.   PLoS One

MicroRNAs in the Pathogenesis of Cancer

(2011) Francesca Lovat et al.   SEMINARS IN ONCOLOGY

Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer

(2011) Robert Mahn et al.   UROLOGY

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

(2010) Nobuyoshi Kosaka et al.   CANCER SCIENCE

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer

(2010) Zhibin Hu et al.   JOURNAL OF CLINICAL ONCOLOGY

A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer

(2010) Hua Zhao et al.   PLoS One

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

(2009) J. W.F. Catto et al.   CANCER RESEARCH

MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells

(2009) Minghua Hu et al.   DIGESTIVE DISEASES AND SCIENCES

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

(2009) Takahiro Ichimi et al.   INTERNATIONAL JOURNAL OF CANCER

Up-regulation of microRNA in bladder tumor tissue is not common

(2009) Gang Wang et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

(2009) Raffaele Baffa et al.   JOURNAL OF PATHOLOGY

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

(2008) Charles H. Lawrie et al.   BRITISH JOURNAL OF HAEMATOLOGY

MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

(2008) Srinivas Veerla et al.   INTERNATIONAL JOURNAL OF CANCER

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A microRNA expression ratio defining the invasive phenotype in bladder tumors

(2008) Lori A. Neely et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS